Embolic protection of saphenous vein graft percutaneous interventions

Journal of Interventional Cardiology

Volumn 20, Issue 5, 2007, Pages 351-358

  Carter, Luther I ^a   Golzar, Jaafer A ^b   Cavendish, Jeffrey J ^a   Dixon, Simon R ^c  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b Heart Care Centers   (United States)

^c WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; POLITEF;

BALLOON CATHETER; BALLOON OCCLUSION; DEATH; DEVICE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; SAPHENOUS VEIN GRAFT; THROMBOEMBOLISM;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BALLOON OCCLUSION; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; HUMANS; RISK FACTORS; SAPHENOUS VEIN; THROMBOEMBOLISM;

EID: 34548803052     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2007.00284.x     Document Type: Review

References (30)

1. Society of Thoracic Surgeons. http://www.sts.org
2. Kytle BW, Loop FD, Cosgrove DM, et al. Long-term (5-12 years) serial studies of internal mammary artery and saphenous vein coronary artery bypass grafts. J Thorac Cardiovasc Surg 1990 1 : 1 20.
3. Goldman S, Zadina K, Moritz T, et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery. J Am Coll Cardiol 2004 44 : 2149 2156.
4. Cameron A, Kemp HG, Green GE. Reoperation for coronary artery disease: 10 years of clinical follow-up. Circulation 1988 78 : I158 I162.
5. Weintraub WS, Jones EL, Morris DC, et al. Outcome of reoperative coronary bypass surgery versus coronary angioplasty after previous bypass surgery. Circulation 1997 95 : 868 877.
6. Morrison DS, Sethi G, Sacks J, et al. Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trail and registry experience for post-CABG patients. J Am Coll Cardiol 2002 40 : 1951 1954.
7. Resnic FS, Wainstein M, Lee MKY, et al. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. Am Heart J 2003 146 : 42 46.
8. Keeley EC, Velez CA, O'Neill WW, et al. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. J Am Coll Cardiol 2001 38 : 659 665.
9. Webb JG, Carere RG, Virmani R, et al. Retrieval and analysis of particulate debris after saphenous vein graft intervention. J Am Coll Cardiol 1999 34 : 468 475.
10. Baldus S, Köster R, Elsner M, et al. Treatment of aortocoronary vein graft lesins with membrane-covered stents. Circulation 2000 102 : 2024 2027.
11. Schächinger V, Hamm CW, Münzel T, et al. A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts. J Am Coll Cardiol 2003 42 : 1360 1369.
12. Stankovic G, Colombo A, Presbitero P, et al. Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: The randomized evaluation of polytetrafluoroethylene covered stent in saphenous vein grafts (RECOVERS) trial. Circulation Jul 2003 108 : 37 42.
13. Ellis SG, Linkoff AM, Miller D, et al. Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. J Am Coll Cardiol 1998 32 : 1619 1623.
14. Roffi M, Mukherjee D, Chew DP, et al. Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatement for percutaneous interventions of aortocoronary bypass grafts: A pooled analysis of five randomized clinical trials. Circulation 2002 106 : 3063 3067.
15. Fischell TA, Subraya RG, Ashraf K, et al. "Pharmacologic" distal protection using prophylactic, intragraft nicardipine to prevent no-reflow and non-Q-wave myocardial infarction during elective saphenous vein graft intervention. J Invasive Cardiol 2007 19 (2 58 62.
16. Grube E, Schofer J, Webb J, et al. Evaluation of a balloon occlusion and aspiration system for protection from distal embolization during stenting in saphenous vein grafts. Am J Cardiol 2002 89 : 941 945.
17. Baim D, Wahr D, George B, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 2002 105 : 1285 1290.
18. Carrozza JP, Mumma M, Breall J, et al. Randomized evaluation of the TriActiv balloon-protection flush and extraction system for the treatment of saphenous vein graft disease. J Am Coll Cardiol 2005 46 : 1677 1683.
19. Sievert H, Wahr D, Schuler G, et al. Effectiveness and safety of the Proxis system in demonstrating retrograde coronary blood flow during proximal occlusion and in capturing embolic material. Am J Cardiol 2004 94 : 1134 1139.
20. Rogers C. Proximal protection during saphenous vein graft intervention using the Proxis embolic protection system: A randomized, prospective, multicenter clinical trial. Presented at Transcatheter Cardiovascular Therapeutics 2005, Washington, DC, October 2005.
21. Stone GW, Rogers C, Feldman R, et al. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation 2003 108 : 548 553.
22. Halkin A, Masud Z, Rogers C, et al. Six-month outcomes after percutaneous intervention for lesions in aortocoronary saphenous vein grafts using distal protection devices: Results from the FIRE trial. Am Heart J 2006 151 : 915.e1 915.e7.
23. Dixon SR. Saphenous vein graft protection in a distal embolic protection randomized trial. Presented at Transcatheter Cardiovascular Therapeutics 2005, Washington, DC, October 2005.
24. Moreno RR, Palacios IF, Leon MN, et al. Histopathologic comparison of human coronary in-stent and post-balloon angioplasty restenotic tissue. Am J Cardiol 1999 84 : 462 466.
25. Kearney M, Pieczek A, Haley L, et al. Histopathology of in-stent restenosis in patients with peripheral artery disease. Circulation 1997 95 : 1988 2002.
26. Ashby D, Dangas G, Aymong E, et al. Effect of percutaneous coronary interventions for in-stent restenosis in degenerated saphenous vein grafts without distal embolic protection. J Am Coll Cardiol 2003 41 : 740 752.
27. Sdringola S, Assali A, Ghani M, et al. Risk assessment of slow or no-reflow phenomenon in aortocoronary vein graft percutaneous intervention. Catheter Cardiovasc Interv 2001 54 : 318 324.
28. Sano K, Mintz G, Carlier S, et al. Intravascular ultrasonic differences between aorto-ostial and shaft narrowing in saphenous veins used as aortocoronary bypass grafts. Am J Cardiol 2006 97 : 1463 1466.
29. Webb L, Dixon S, Safian R, O'Neill W. Usefulness of embolic protection devices during saphenous vein graft intervention in a nonselected population. J Interv Cardiol 2005 18 : 73 75.
30. Rogers C, Huynh R, Seifert P, et al. Embolic protection with filtering or occlusion balloons during saphenous vein graft stenting retrieves identical volumes and sizes of particulate debris. Circulation 2004 109 (14 1735 1740.